Acasti Pharma Inc. (NASDAQ:ACST) Forecast to loss -48.98% to hit Consensus price target – Marketing Sentinel

Acasti Pharma Inc. (NASDAQ:ACST) Forecast to loss -48.98% to hit Consensus price target

Acasti Pharma Inc. (NASDAQ:ACST) has a beta value of 0 and has seen 8,193,092 shares traded in the last trading session. The company, currently valued at $96.17 Million, closed the last trade at $0.49 per share which meant it lost -$0.01 on the day or -0.44% during that session. The ACST stock price is -148.98% off its 52-week high price of $1.22 and 65.31% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.94 Million shares traded. The 3-month trading volume is 38.42 Million shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The consensus among analysts is that Acasti Pharma Inc. (ACST) is a Hold stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 1 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.16.

Acasti Pharma Inc. (NASDAQ:ACST) trade information

Despite being -0.44% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Apr 27 when the ACST stock price touched $0.5693 or saw a rise of 13.4%. Year-to-date, Acasti Pharma Inc. shares have moved 51.69%, while the 5-day performance has seen it change 5.91%. Over the past 30 days, the shares of Acasti Pharma Inc. (NASDAQ:ACST) have changed -16.44%. Short interest in the company has seen 2.98 Million shares shorted with days to cover at 0.08.

Wall Street analysts have a consensus price target for the stock at $0.25, which means that the shares’ value could jump -48.98% from current levels. The projected low price target is $0.25 while the price target rests at a high of $0.25. In that case, then, we find that the current price level is -48.98% off the targeted high while a plunge would see the stock lose -48.98% from current levels.

Acasti Pharma Inc. (ACST) estimates and forecasts

Earnings growth for 2021 is a modest +30.3%.

Acasti Pharma Inc. (NASDAQ:ACST)’s Major holders

Insiders own 2.7% of the company shares, while shares held by institutions stand at 2.21% with a share float percentage of 2.27%. Investors are also buoyed by the number of investors in a company, with Acasti Pharma Inc. having a total of 30 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 1.92 Million shares worth more than $625.3 Thousand. As of December 30, 2020, Renaissance Technologies, LLC held 0.92% of shares outstanding.

The other major institutional holder is Virtu Financial LLC, with the holding of over 687.99 Thousand shares as of December 30, 2020. The firm’s total holdings are worth over $223.6 Thousand and represent 0.33% of shares outstanding.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.